Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
4.020
+0.020 (0.50%)
Dec 24, 2025, 1:00 PM EST - Market closed
Tvardi Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$51.67
Upside
+1,185.32%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 14, 2025 |
| BTIG | BTIG | Strong Buy Maintains $55 → $15 | Strong Buy | Maintains | $55 → $15 | +273.13% | Oct 13, 2025 |
| Barclays | Barclays | Buy Initiates $61 | Buy | Initiates | $61 | +1,417.41% | Oct 13, 2025 |
| Raymond James | Raymond James | Buy Initiates $62 | Buy | Initiates | $62 | +1,442.29% | Jul 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $52 | Buy | Initiates | $52 | +1,193.53% | Jul 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $78 | Buy | Initiates | $78 | +1,840.30% | Jun 12, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $65 | Buy | Initiates | $65 | +1,516.92% | May 21, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +870.15% | Apr 28, 2025 |